{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:48:49Z","timestamp":1787496529996,"version":"build-2736575974"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","theclinics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medical Clinics of North America"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/j.mcna.2018.10.003","type":"journal-article","created":{"date-parts":[[2018,12,3]],"date-time":"2018-12-03T17:58:15Z","timestamp":1543859895000},"page":"215-233","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Migraine and Tension-Type Headache"],"prefix":"10.1016","volume":"103","author":[{"given":"Rebecca","family":"Burch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10100","key":"10.1016\/j.mcna.2018.10.003_bib1","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1016\/S0140-6736(17)32154-2","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"issue":"4","key":"10.1016\/j.mcna.2018.10.003_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/head.13281","article-title":"The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies","volume":"58","author":"Burch","year":"2018","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.mcna.2018.10.003_bib3","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1046\/j.1526-4610.2001.041007646.x","article-title":"Prevalence and burden of migraine in the United States: data from the American Migraine Study II","volume":"41","author":"Lipton","year":"2001","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.mcna.2018.10.003_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/JOM.0b013e3181c1dc56","article-title":"Employment and work impact of chronic migraine and episodic migraine","volume":"52","author":"Stewart","year":"2010","journal-title":"J\u00a0Occup Environ Med"},{"key":"10.1016\/j.mcna.2018.10.003_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/head.12774","article-title":"Assessing barriers to chronic migraine consultation, diagnosis, and treatment: results from the chronic migraine epidemiology and outcomes (CaMEO) study","author":"Dodick","year":"2016","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.mcna.2018.10.003_bib6","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1001\/jama.279.5.381","article-title":"Epidemiology of tension-type headache","volume":"279","author":"Schwartz","year":"1998","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.mcna.2018.10.003_bib7","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1055\/s-0038-1646946","article-title":"The global burden of headache","volume":"38","author":"Saylor","year":"2018","journal-title":"Semin Neurol"},{"key":"10.1016\/j.mcna.2018.10.003_bib8","unstructured":"International Classification of Headache Disorders (ICHD). ICHD-3 The International Classification of Headache Disorders 3rd edition. ICHD-3 The International Classification of Headache Disorders 3rd edition. Available at: https:\/\/www.ichd-3.org\/. Accessed June 24, 2018."},{"issue":"9 Suppl 6","key":"10.1016\/j.mcna.2018.10.003_bib9","first-page":"S27","article-title":"Diagnostic lessons from the spectrum study","volume":"58","author":"Lipton","year":"2002","journal-title":"Neurology"},{"issue":"8","key":"10.1016\/j.mcna.2018.10.003_bib10","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1111\/j.1526-4610.2010.01753.x","article-title":"An analysis of migraine triggers in a clinic-based population","volume":"50","author":"Andress-Rothrock","year":"2010","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.mcna.2018.10.003_bib11","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1177\/0333102414535110","article-title":"Prevalence of neck pain in migraine and tension-type headache: a population study","volume":"35","author":"Ashina","year":"2015","journal-title":"Cephalalgia"},{"issue":"2","key":"10.1016\/j.mcna.2018.10.003_bib12","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/j.1526-4610.2006.00688.x","article-title":"The sinus, allergy and migraine study (SAMS)","volume":"47","author":"Eross","year":"2007","journal-title":"Headache"},{"issue":"10","key":"10.1016\/j.mcna.2018.10.003_bib13","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1007\/s11916-014-0453-0","article-title":"Our evolving understanding of migraine with aura","volume":"18","author":"DeLange","year":"2014","journal-title":"Curr Pain Headache Rep"},{"issue":"4","key":"10.1016\/j.mcna.2018.10.003_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1046\/j.1468-2982.1996.1604239.x","article-title":"Migraine without aura and migraine with aura are distinct clinical entities: a study of four hundred and eighty-four male and female migraineurs from the general population","volume":"16","author":"Russell","year":"1996","journal-title":"Cephalalgia"},{"issue":"6241","key":"10.1016\/j.mcna.2018.10.003_bib15","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1136\/bmj.281.6241.658","article-title":"Migraine prodromes separated from the aura: complete migraine","volume":"281","author":"Blau","year":"1980","journal-title":"Br Med J"},{"issue":"7","key":"10.1016\/j.mcna.2018.10.003_bib16","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1526-4610.1995.hed3507387.x","article-title":"Migraine symptoms: results of a survey of self-reported migraineurs","volume":"35","author":"Silberstein","year":"1995","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.mcna.2018.10.003_bib17","doi-asserted-by":"crossref","first-page":"e020498","DOI":"10.1136\/bmjopen-2017-020498","article-title":"Migraine and the risk of cardiovascular and cerebrovascular events: a meta-analysis of 16 cohort studies including 1 152 407 subjects","volume":"8","author":"Mahmoud","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.mcna.2018.10.003_bib18","unstructured":"World Health Organization (WHO). Medical eligibility criteria for contraceptive use. 2016. Available at: http:\/\/www.who.int\/reproductivehealth\/publications\/family_planning\/Ex-Summ-MEC-5\/en\/. Accessed June 24, 2018."},{"issue":"6","key":"10.1016\/j.mcna.2018.10.003_bib19","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/00006250-200606000-00055","article-title":"ACOG practice bulletin. No. 73: use of hormonal contraception in women with coexisting medical conditions","volume":"107","year":"2006","journal-title":"Obstet Gynecol"},{"issue":"1","key":"10.1016\/j.mcna.2018.10.003_bib20","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/head.13229","article-title":"Risk of stroke associated with use of estrogen containing contraceptives in women with migraine: a systematic review","volume":"58","author":"Sheikh","year":"2018","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.mcna.2018.10.003_bib21","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ncl.2008.11.009","article-title":"Diagnostic testing for migraine and other primary headaches","volume":"27","author":"Evans","year":"2009","journal-title":"Neurol Clin"},{"issue":"2","key":"10.1016\/j.mcna.2018.10.003_bib22","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.otc.2013.10.010","article-title":"Red flags and comfort signs for ominous secondary headaches","volume":"47","author":"Cady","year":"2014","journal-title":"Otolaryngol Clin North Am"},{"issue":"6","key":"10.1016\/j.mcna.2018.10.003_bib23","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1177\/1756285613489765","article-title":"The role of neuroimaging in the diagnosis of headache disorders","volume":"6","author":"Holle","year":"2013","journal-title":"Ther Adv Neurol Disord"},{"key":"10.1016\/j.mcna.2018.10.003_bib24","series-title":"Radiation emissions from computed tomography: a review of the risk of cancer and guidelines","year":"2014"},{"issue":"4","key":"10.1016\/j.mcna.2018.10.003_bib25","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1212\/01.CON.0000418645.32032.32","article-title":"Tension-type headache","volume":"18","author":"Kaniecki","year":"2012","journal-title":"Continuum"},{"issue":"11","key":"10.1016\/j.mcna.2018.10.003_bib26","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/j.1468-1331.2010.03070.x","article-title":"EFNS guideline on the treatment of tension-type headache - report of an EFNS task force","volume":"17","author":"Bendtsen","year":"2010","journal-title":"Eur J Neurol"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2018.10.003_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10072-014-1735-3","article-title":"Treatment of tension-type headache: from old myths to modern concepts","volume":"35","author":"Barbanti","year":"2014","journal-title":"Neurol Sci"},{"issue":"6","key":"10.1016\/j.mcna.2018.10.003_bib28","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11916-009-0075-0","article-title":"Tension-type headache with medication overuse: pathophysiology and clinical implications","volume":"13","author":"Monteith","year":"2009","journal-title":"Curr Pain Headache Rep"},{"issue":"10","key":"10.1016\/j.mcna.2018.10.003_bib29","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1111\/j.1526-4610.2000.00143.x","article-title":"2000 Wolfe Award. Sumatriptan for the range of headaches in migraine sufferers: results of the Spectrum Study","volume":"40","author":"Lipton","year":"2000","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.mcna.2018.10.003_bib30","article-title":"Selective serotonin reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs) for the prevention of tension-type headache in adults","author":"Banzi","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"10","key":"10.1016\/j.mcna.2018.10.003_bib31","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1526-4610.1992.hed3210509.x","article-title":"Tizanidine in chronic tension-type headache: a placebo controlled double-blind cross-over study","volume":"32","author":"Fogelholm","year":"1992","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.mcna.2018.10.003_bib32","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1212\/WNL.55.6.754","article-title":"Practice parameter: evidence-based guidelines for migraine headache (an evidence-based review): report of the quality standards subcommittee of the American Academy of Neurology","volume":"55","author":"Silberstein","year":"2000","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.mcna.2018.10.003_bib33","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1111\/head.12362","article-title":"Behavioral and mind\/body interventions in headache: unanswered questions and future research directions","volume":"54","author":"Wells","year":"2014","journal-title":"Headache"},{"issue":"4","key":"10.1016\/j.mcna.2018.10.003_bib34","first-page":"669","article-title":"The impact of regular lifestyle behavior in migraine: a prevalence case-referent study","volume":"263","author":"Woldeamanuel","year":"2016","journal-title":"J\u00a0Neurol"},{"key":"10.1016\/j.mcna.2018.10.003_bib35","article-title":"Lifestyle factors and risk of migraine and tension-type headache. Follow-up data from the Nord-Tr\u00f8ndelag Health Surveys 1995-1997 and 2006-2008","author":"Hagen","year":"2018","journal-title":"Cephalalgia"},{"key":"10.1016\/j.mcna.2018.10.003_bib36","doi-asserted-by":"crossref","DOI":"10.1111\/head.13313","article-title":"Cognitive-behavioral therapy for insomnia to reduce chronic migraine: a sequential Bayesian analysis","author":"Smitherman","year":"2018","journal-title":"Headache"},{"issue":"9","key":"10.1016\/j.mcna.2018.10.003_bib37","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1111\/head.12953","article-title":"Diet and headache: part 1","volume":"56","author":"Martin","year":"2016","journal-title":"Headache"},{"issue":"9","key":"10.1016\/j.mcna.2018.10.003_bib38","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/head.12952","article-title":"Diet and headache: part 2","volume":"56","author":"Martin","year":"2016","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.mcna.2018.10.003_bib39","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11910-017-0721-6","article-title":"A\u00a0clinical approach to addressing diet with migraine patients","volume":"17","author":"Slavin","year":"2017","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"17","key":"10.1016\/j.mcna.2018.10.003_bib40","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1212\/WNL.0b013e3182535d0c","article-title":"Evidence-based guideline update: NSAIDs and other complementary treatments for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"78","author":"Holland","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2018.10.003_bib41","unstructured":"Migraine preventative butterbur has safety concerns | Neurology Times. Available at: http:\/\/www.neurologytimes.com\/headache-and-migraine\/migraine-preventative-butterbur-has-safety-concerns. Accessed June 24, 2018."},{"issue":"6","key":"10.1016\/j.mcna.2018.10.003_bib42","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1111\/head.12570","article-title":"Comprehensive review of medicinal marijuana, cannabinoids, and therapeutic implications in medicine and headache: what a long strange trip it\u2019s been \u2026","volume":"55","author":"Baron","year":"2015","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.mcna.2018.10.003_bib43","first-page":"36","article-title":"Marijuana induced reversible cerebral vasoconstriction syndrome","volume":"8","author":"Uhegwu","year":"2015","journal-title":"J\u00a0Vasc Interv Neurol"},{"issue":"4","key":"10.1016\/j.mcna.2018.10.003_bib44","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/head.12794","article-title":"Reversible cerebral vasoconstriction syndrome without typical thunderclap headache","volume":"56","author":"Wolff","year":"2016","journal-title":"Headache"},{"issue":"4 Headache","key":"10.1016\/j.mcna.2018.10.003_bib45","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1212\/CON.0000000000000192","article-title":"Acute migraine treatment","volume":"21","author":"Becker","year":"2015","journal-title":"Continuum"},{"issue":"9","key":"10.1016\/j.mcna.2018.10.003_bib46","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1111\/j.1526-4610.2009.01465.x","article-title":"The relative efficacy of phenothiazines for the treatment of acute migraine: a meta-analysis","volume":"49","author":"Kelly","year":"2009","journal-title":"Headache"},{"issue":"1","key":"10.1016\/j.mcna.2018.10.003_bib47","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1186\/s10194-016-0696-8","article-title":"Risk of medication overuse headache across classes of treatments for acute migraine","volume":"17","author":"Thorlund","year":"2016","journal-title":"J\u00a0Headache Pain"},{"issue":"8","key":"10.1016\/j.mcna.2018.10.003_bib48","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1111\/j.1526-4610.2008.01217.x","article-title":"Acute migraine medications and evolution from episodic to chronic migraine: a longitudinal population-based study","volume":"48","author":"Bigal","year":"2008","journal-title":"Headache"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2018.10.003_bib49","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/j.1526-4610.2012.02140.x","article-title":"Opioids should not be used in migraine","volume":"52","author":"Tepper","year":"2012","journal-title":"Headache"},{"issue":"3","key":"10.1016\/j.mcna.2018.10.003_bib50","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/j.1526-4610.2006.00631.x","article-title":"Patterns of diagnosis and acute and preventive treatment for migraine in the United States: results from the American Migraine Prevalence and Prevention study","volume":"47","author":"Diamond","year":"2007","journal-title":"Headache"},{"key":"10.1016\/j.mcna.2018.10.003_bib51","doi-asserted-by":"crossref","first-page":"g2285","DOI":"10.1136\/bmj.g2285","article-title":"Triptans for symptomatic treatment of migraine headache","volume":"348","author":"Pringsheim","year":"2014","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.mcna.2018.10.003_bib52","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1056\/NEJMct0910887","article-title":"Triptan therapy in migraine","volume":"363","author":"Loder","year":"2010","journal-title":"N\u00a0Engl J Med"},{"issue":"6","key":"10.1016\/j.mcna.2018.10.003_bib53","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1111\/j.1526-4610.2010.01691.x","article-title":"The FDA alert on serotonin syndrome with use of triptans combined with selective serotonin reuptake inhibitors or selective serotonin-norepinephrine reuptake inhibitors: American Headache Society position paper","volume":"50","author":"Evans","year":"2010","journal-title":"Headache"},{"issue":"5","key":"10.1016\/j.mcna.2018.10.003_bib54","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1001\/jamaneurol.2017.5144","article-title":"Association of coprescription of triptan antimigraine drugs and selective serotonin reuptake inhibitor or selective norepinephrine reuptake inhibitor antidepressants with serotonin syndrome","volume":"75","author":"Orlova","year":"2018","journal-title":"JAMA Neurol"},{"issue":"2","key":"10.1016\/j.mcna.2018.10.003_bib55","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1526-4610.2005.05031.x","article-title":"Triptan nonresponder studies: implications for clinical practice","volume":"45","author":"Dodick","year":"2005","journal-title":"Headache"},{"issue":"2","key":"10.1016\/j.mcna.2018.10.003_bib56","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00002018-200326020-00003","article-title":"Tolerability of the triptans: clinical implications","volume":"26","author":"Nappi","year":"2003","journal-title":"Drug Saf"},{"issue":"7","key":"10.1016\/j.mcna.2018.10.003_bib57","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1185\/03007995.2013.787980","article-title":"Efficacy endpoints in migraine clinical trials: the importance of assessing freedom from pain","volume":"29","author":"Silberstein","year":"2013","journal-title":"Curr Med Res Opin"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2018.10.003_bib58","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1046\/j.1526-4610.2002.0420s1003.x","article-title":"What do patients with migraine want from acute migraine treatment?","volume":"42","author":"Lipton","year":"2002","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.mcna.2018.10.003_bib59","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1212\/WNL.0000000000001256","article-title":"Ineffective acute treatment of episodic migraine is associated with new-onset chronic migraine","volume":"84","author":"Lipton","year":"2015","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.mcna.2018.10.003_bib60","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1111\/j.1526-4610.2012.02292.x","article-title":"Frequency and burden of headache-related nausea: results from the American Migraine Prevalence and Prevention (AMPP) study","volume":"53","author":"Lipton","year":"2013","journal-title":"Headache"},{"issue":"Suppl 22","key":"10.1016\/j.mcna.2018.10.003_bib61","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/0333102498018S2208","article-title":"Disability assessment as a basis for stratified care","volume":"18","author":"Lipton","year":"1998","journal-title":"Cephalalgia"},{"issue":"10","key":"10.1016\/j.mcna.2018.10.003_bib62","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1177\/0333102416663459","article-title":"Acute migraine medication adherence, migraine disability and patient satisfaction: a naturalistic daily diary study","volume":"37","author":"Seng","year":"2017","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.mcna.2018.10.003_bib63","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/j.1468-2982.2008.01546.x","article-title":"Early vs. non-early intervention in acute migraine-\u2019Act when Mild (AwM)'. A double-blind, placebo-controlled trial of almotriptan","volume":"28","author":"Goadsby","year":"2008","journal-title":"Cephalalgia"},{"issue":"12","key":"10.1016\/j.mcna.2018.10.003_bib64","doi-asserted-by":"crossref","first-page":"655","DOI":"10.3109\/00207454.2011.605191","article-title":"The impact of allodynia on the efficacy of almotriptan when given early in migraine: data from the \u201cAct when mild\u201d study","volume":"121","author":"D\u00edaz-Insa","year":"2011","journal-title":"Int J Neurosci"},{"issue":"1","key":"10.1016\/j.mcna.2018.10.003_bib65","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1007\/s11910-014-0509-x","article-title":"Medication overuse headache","volume":"15","author":"Cheung","year":"2015","journal-title":"Curr Neurol Neurosci Rep"},{"issue":"12","key":"10.1016\/j.mcna.2018.10.003_bib66","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1212\/WNL.0000000000004371","article-title":"Medication overuse headache: an entrenched idea in need of scrutiny","volume":"89","author":"Scher","year":"2017","journal-title":"Neurology"},{"key":"10.1016\/j.mcna.2018.10.003_bib67","article-title":"Evidence-based guidelines for\u00a0migraine headache in the primary care setting: pharmacological management of acute attacks","volume":"54","author":"Matchar","year":"2000","journal-title":"Neurology"},{"issue":"Suppl 1","key":"10.1016\/j.mcna.2018.10.003_bib68","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/head.12111","article-title":"Why triptan treatment can fail: focus on gastrointestinal manifestations of migraine","volume":"53","author":"Newman","year":"2013","journal-title":"Headache"},{"issue":"6","key":"10.1016\/j.mcna.2018.10.003_bib69","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/head.12835","article-title":"Management of adults with acute migraine in the emergency department: the American Headache Society evidence assessment of parenteral pharmacotherapies","volume":"56","author":"Orr","year":"2016","journal-title":"Headache"},{"issue":"11","key":"10.1016\/j.mcna.2018.10.003_bib70","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1177\/0333102414566200","article-title":"The place of corticosteroids in migraine attack management: a 65-year systematic review with pooled analysis and critical appraisal","volume":"35","author":"Woldeamanuel","year":"2015","journal-title":"Cephalalgia"},{"issue":"3","key":"10.1016\/j.mcna.2018.10.003_bib71","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1111\/j.1526-4610.2012.02097.x","article-title":"Rescue therapy for acute migraine, part 3: opioids, NSAIDs, steroids, and post-discharge medications","volume":"52","author":"Kelley","year":"2012","journal-title":"Headache"},{"issue":"4 Headache","key":"10.1016\/j.mcna.2018.10.003_bib72","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1212\/CON.0000000000000191","article-title":"Emergency department and inpatient management of status migrainosus and intractable headache","volume":"21","author":"Rozen","year":"2015","journal-title":"Continuum"},{"issue":"7","key":"10.1016\/j.mcna.2018.10.003_bib73","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1046\/j.1468-2982.2002.00386.x","article-title":"Migraine: preventive treatment","volume":"22","author":"Silberstein","year":"2002","journal-title":"Cephalalgia"},{"issue":"6","key":"10.1016\/j.mcna.2018.10.003_bib74","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1136\/jnnp.2007.134023","article-title":"Migraine prevention","volume":"7","author":"Dodick","year":"2007","journal-title":"Pract Neurol"},{"issue":"8","key":"10.1016\/j.mcna.2018.10.003_bib75","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1046\/j.1468-2982.2003.00590.x","article-title":"Patients\u2019 decision-making for migraine and chronic daily headache management. A qualitative study","volume":"23","author":"Peters","year":"2003","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.mcna.2018.10.003_bib76","first-page":"22","article-title":"Systematic review of migraine prophylaxis adherence and persistence","volume":"20","author":"Hepp","year":"2014","journal-title":"J\u00a0Manag Care Pharm"},{"key":"10.1016\/j.mcna.2018.10.003_bib77","series-title":"Headache in clinical practice","author":"Silberstein","year":"2018"},{"issue":"3","key":"10.1016\/j.mcna.2018.10.003_bib78","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/clpt.2008.203","article-title":"Are migraineurs at increased risk of adverse drug responses? A meta-analytic comparison of topiramate-related adverse drug reactions in epilepsy and migraine","volume":"85","author":"Luykx","year":"2009","journal-title":"Clin Pharmacol Ther"},{"issue":"4 Headache","key":"10.1016\/j.mcna.2018.10.003_bib79","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/CON.0000000000000199","article-title":"Preventive migraine treatment","volume":"21","author":"Silberstein","year":"2015","journal-title":"Continuum"},{"issue":"6","key":"10.1016\/j.mcna.2018.10.003_bib80","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/s41582-018-0003-1","article-title":"CGRP as the target of new migraine therapies - successful translation from bench to clinic","volume":"14","author":"Edvinsson","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.mcna.2018.10.003_bib81","unstructured":"Migraine: Final Report - ICER. ICER. Available at: https:\/\/icer-review.org\/material\/cgrp-final-report\/. Accessed September 22, 2018."},{"issue":"1","key":"10.1016\/j.mcna.2018.10.003_bib82","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/s10194-017-0807-1","article-title":"Blocking CGRP in migraine patients \u2013 a review of pros and cons","volume":"18","author":"Deen","year":"2017","journal-title":"J\u00a0Headache Pain"},{"issue":"9","key":"10.1016\/j.mcna.2018.10.003_bib83","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1001\/jamaneurol.2018.1268","article-title":"Who should try new antibody treatments for migraine?","volume":"75","author":"Loder","year":"2018","journal-title":"JAMA Neurol"},{"issue":"17","key":"10.1016\/j.mcna.2018.10.003_bib84","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1212\/WNL.0b013e3182535d20","article-title":"Evidence-based guideline update: pharmacologic treatment for episodic migraine prevention in adults: report of the Quality Standards Subcommittee of the American Academy of Neurology and the American Headache Society","volume":"78","author":"Silberstein","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"10.1016\/j.mcna.2018.10.003_bib85","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1111\/j.1526-4610.2012.02185.x","article-title":"The 2012 AHS\/AAN guidelines for prevention of episodic migraine: a summary and comparison with other recent clinical practice guidelines","volume":"52","author":"Loder","year":"2012","journal-title":"Headache"},{"issue":"8","key":"10.1016\/j.mcna.2018.10.003_bib86","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/nrneurol.2016.93","article-title":"Chronic migraine: risk factors, mechanisms and treatment","volume":"12","author":"May","year":"2016","journal-title":"Nat Rev Neurol"},{"issue":"4","key":"10.1016\/j.mcna.2018.10.003_bib87","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7861\/clinmedicine.15-4-344","article-title":"Integrated care for chronic migraine patients: epidemiology, burden, diagnosis and treatment options","volume":"15","author":"Diener","year":"2015","journal-title":"Clin Med"},{"key":"10.1016\/j.mcna.2018.10.003_bib88","doi-asserted-by":"crossref","first-page":"g1416","DOI":"10.1136\/bmj.g1416","article-title":"Chronic migraine","volume":"348","author":"Schwedt","year":"2014","journal-title":"BMJ"},{"issue":"19","key":"10.1016\/j.mcna.2018.10.003_bib89","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1212\/WNL.0000000000002560","article-title":"Practice guideline update summary: botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity, and headache: report of the guideline development subcommittee of the American Academy of Neurology","volume":"86","author":"Simpson","year":"2016","journal-title":"Neurology"}],"container-title":["Medical Clinics of North America"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712518301251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025712518301251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,21]],"date-time":"2025-09-21T01:42:56Z","timestamp":1758418976000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025712518301251"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S0025712518301251"],"URL":"https:\/\/doi.org\/10.1016\/j.mcna.2018.10.003","relation":{},"ISSN":["0025-7125"],"issn-type":[{"value":"0025-7125","type":"print"}],"subject":[],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Migraine and Tension-Type Headache","name":"articletitle","label":"Article Title"},{"value":"Medical Clinics of North America","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcna.2018.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}